
Astonea Labs Ltd SME IPO
Astonea Labs Limited plans to use a book-building approach to conduct its SME IPO with a target capital raise of 37.67 crore. To do this, 27.9 lakh new equity shares with a face value of ₹10 apiece would be issued. On May 27, 2025, the subscription window will open, and it will end on May 29, 2025. By June 3, 2025, the shares should be listed on the BSE SME platform. With a price range of ₹128 to ₹135 per share and a minimum investment of ₹1,35,000 at the top limit, the lot size for retail investors is set at 1,000 shares.
Operations & Product Range
Facility & Production:
Astonea Labs runs a 200,000 sq. ft. production plant in Panchkula, Haryana. It operates dedicated sections for manufacturing tablets, capsules, softgels, powders, creams, ointments, and lotions. The company caters to both domestic and global markets, including exports to Iraq and Yemen, and is active in contract manufacturing of critical pharmaceutical products.
Brands & Market Presence:
It markets proprietary brands such as "Glow Up" (skincare) and "Regero" (pharma), with plans to introduce a new product line named "Avicel".
Revenue Channels
- Contract manufacturing in pharmaceuticals, cosmetics, and nutraceuticals
- Direct sales of in-house branded products in Indian and overseas markets

WHAT IS GMP?
GMP (Grey Market Premium) is the difference between the IPO price and the grey market price. It is the premium amount paid for the traded IPO shares. It plays an important role in IPOs as it reflects how the IPO would react on the listing day.
A grey market is a place where shares/stocks are traded before being listed officially on the stock exchange.
Astonea Labs Ltd SME IPO
GMP Date | IPO Price | GMP | Last Updated |
---|---|---|---|
- | - | - | - |
**The GMP prices displayed here are solely for informational purposes related to the grey market news. India IPO does not engage in or facilitate grey market trading, nor are these rates (sub2) indicative of any trading activity. We also do not recommend or endorse participation in the grey market.**
Astonea Labs Ltd SME IPO Details
Detail | Description |
---|---|
IPO Date | May 27, 2025 to May 29, 2025 |
Listing Date | - |
Face Value | ₹10 per share |
Issue Price Band | ₹128 to ₹135 per share |
Lot Size | 1,000 Shares |
Total Issue Size | 27,90,000 shares (aggregating up to ₹37.67 Cr) |
Fresh Issue | 27,90,000 shares (aggregating up to ₹37.67 Cr) |
Issue Type | Bookbuilding IPO |
Listing At | BSE SME |
Share Holding Pre Issue | 77,21,000 shares |
Share Holding Post Issue | 1,05,11,000 shares |
Market Maker Portion | 1,44,000 shares |
Astonea Labs Ltd SME IPO Timeline
Detail | Description |
---|---|
IPO Open Date | Tue, May 27, 2025 |
IPO Close Date | Thu, May 29, 2025 |
Tentative Allotment | Fri, May 30, 2025 |
Initiation of Refunds | Mon, Jun 2, 2025 |
Credit of Shares to Demat | Mon, Jun 2, 2025 |
Tentative Listing Date | Tue, Jun 3, 2025 |
Cut-off time for UPI mandate confirmation | 5 PM on May 29, 2025 |
Astonea Labs Ltd SME IPO Lot Size
Application | Lots | Shares | Amount |
---|---|---|---|
Retail (Min) | 1 | 1,000 | ₹1,35,000 |
Retail (Max) | 1 | 1,000 | ₹1,35,000 |
HNI (Min) | 2 | 2,000 | ₹2,70,000 |
Astonea Labs Ltd SME IPO Promoter Holding
Share Holding Pre Issue | Share Holding Post Issue |
---|---|
98.42% | - |
Competitive Strength:
- ● Advanced Manufacturing Facility
- ● Wide Product Portfolio
- ● Certified Quality Standards
- ● Solid Financials
- ● Export-Oriented Strategy
- ● R&D Focused
Astonea Labs Ltd SME IPO Financial Information
Period Ended | Assets | Revenue | Profit After Tax | Net Worth | Total Borrowing | |||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
31 Dec 2024 | 96.52 | 69.69 | 4.1 | 17.28 | 49.48 | |||||||||||||||||||||||||||||||||||
31 Mar 2024 | 80.89 | 80.29 | 4 | 11.97 | 42.40 | |||||||||||||||||||||||||||||||||||
31 Mar 2023 | 64.28 | 67.26 | 0.67 | 8.16 | 35.99 | |||||||||||||||||||||||||||||||||||
31 Mar 2022 | 52.91 | 30.17 | 0.25 | 7.49 | 29.52 | |||||||||||||||||||||||||||||||||||
Amount in ₹ Crore |
Key Performance Indicator
KPI | Values |
---|---|
ROE | 37.86% |
ROCE | 22.95% |
Debt/Equity | 2.16 |
RoNW | 31.83% |
PAT Margin | 4.75 |
Price to Book Value | 8.57 |
Pre IPO | Post IPO | |
---|---|---|
EPS (Rs) | 4.93 | 5.20 |
P/E (x) | 27.36 | 25.94 |
IPO Objectives
The net proceeds will be allocated toward:
- Funding working capital
- Purchasing plant and machinery, particularly for ointment production
- Marketing and brand awareness campaigns
- IT infrastructure investments
- Covering costs for product registration in Bolivia
- General corporate expenses
Conclusion
Astonea Labs' IPO presents an opportunity to invest in a dynamic and export-focused pharmaceutical and cosmeceutical manufacturer. The company’s strong infrastructure, diversified product line, certified processes, and expanding global reach form a solid foundation for long-term growth. The capital raised will further fuel expansion, enhance capabilities, and strengthen its brand footprint globally.
RHP:
DRHP:
Read more :
- Nikita Papers Limited IPO
- Schloss Bangalore Limited IPO (Leela Hotels IPO)
- Aegis Vopak Terminals Limited IPO
Frequently asked Questions (FAQs )
-
1. What is the IPO price band and lot size?
₹128–₹135 per share, with a minimum lot of 1,000 shares. Investment at the top band requires ₹1,35,000.
-
2. What is the total issue size?
₹37.67 crore via a fresh issue of 27.9 lakh equity shares. There is no offer-for-sale component.
-
3. How will the IPO proceeds be used?
For working capital, equipment purchase, branding, IT upgrades, Bolivia registration, and general purposes.
-
4. When are the allotment and listing dates?
The IPO closes on May 29, 2025. Listing is expected on June 3, 2025, on the BSE SME platform.
-
5. How is market sentiment?
As of May 28, 2025, the grey market premium is flat at ₹135, indicating neutral sentiment.